No “repair issue” at Lifecare

Lifecare is trading at NOK 2.5, the price of the recently completed private placement, and there is therefore no need for a public issue at the same price. The issue of up to 3 million shares is therefore cancelled.

Lifecare: Ticker: LIFE | Price: NOK 2.50 | Market Cap.: 260 MNOK | YTD price development: 47%

Lifecare is a Medtech company that develops a smart and revolutionary biosensor that, when inserted in the wrist for example, continuously monitors the glucose (sugar) level in the blood and displays it via e.g. a smart watch. This is badly needed by the more than 500 million patients with diabetes, but at the moment the most common method is to take blood samples several times a day. Lifecare’s sensor can also be used to detect other biomarkers, but currently the company’s focus is diabetes and to launch Sencell Glucose in 2024.

The market price is below the theoretical price

The share price of Lifecare fell from NOK 3.40 before the announcement of the private placement to NOK 2.50. The theoretical share price is 3.2. At NOK 2.50, shares are thus trading below the theoretical price.

Price development of Lifecare AS vs. Kapital Partners Healthcare Index

Would you like to receive one of our newsletters? Please fill the form below. (Newsletters are in danish)

  • Investment cases  – Newsletters with current investment cases from the Nordic growth exchanges and the life science sector.
  • IPOs – Updates on new and ongoing IPOs in Scandinavia and their results. (Newsletter from
  • News – News from and about Kapital Partner, including insight into the capital markets and stock exchange listings as well as invitations to investor meetings and events.

*If you want information about our upcoming investment association with a focus on the Nordic growth exchanges, including the opportunity to invest, sign up for the newsletter. Nyheder.

Investor network:

Do you want to be part of Kapital Partner’s investor network, where you get access to investments in companies and issues, as well as invitations to investor-oriented events,
please fill out the form in here.

Del indlægget på sociale media eller på email.